Drug
Tak 360
Tak 360: highest development phase Phase 2/3, developed by Takeda. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2/3
- Developer
- Takeda
Trials
| Drug | Phase | Indication |
|---|---|---|
| TAK-360 NCT07646678 | Phase 2/3 | Idiopathic Hypersomnia |
Latest
No recent events.
Follow Tak 360 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.